Clinical Trial Update: Tuvusertib in Astrocytoma With ATRX Mutation [Phase 2]

View source ↗

Summary

A phase 2 trial of Tuvusertib in astrocytoma with ATRX mutation is currently recruiting. The study is sponsored by Grupo Español de Investigación en Neurooncolo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma

Drugs mentioned

• Tuvusertib (tuvusertib)

Snippet

Sponsor: Grupo Español de Investigación en Neurooncología | Conditions: Astrocytoma | Phase 2 | Status: RECRUITING